Please provide your email address to receive an email when new articles are posted on . There is a disconnect between cough scientists and the FDA in what represents a meaningful outcome for chronic ...
VANCOUVER, British Columbia, July 16, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical ...
Findings of a systematic review highlight the need for standardized assessment tools and targeted treatments for chronic cough in patients with idiopathic pulmonary fibrosis and other interstitial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results